CCSV - Post Market Clinical Follow-up Study
Key facts
- Who runs it
- Medical University of Vienna
- Where
- Austria1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 1 Jun 2024
- Ended
- 31 Mar 2026
- Type of study
- Observational, 2 groups
- Record updated
- 20 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- OHCA
- Correct endotracheal intubation (seen by capnography)
- The patient is being treated by the Vienna Emergency Medical Services within the scope of emergency ventilation
- MEDUMAT Standard from Weinmann Emergency is used
- Mechanical ventilation is performed according to the specified indications
Who cannot take part
- Traumatic cardiac arrest
- Patients eligible for eCPR (as defined by the standard operating procedure of the Emergency Medical Service Vienna)
- Patients recovering (reaching sustained ROSC) before starting mechanical ventilation or in the first three minutes of it
- Any other mechanical ventilation during the ongoing CPR before study inclusion
- Suspected or known pregnancy
- Clinically suspected (tension-)pneumothorax
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main goal of this observational study is the evaluation of Chest Compression Synchronized Ventilation (CCSV) regarding oxygenation in terms of PaO2 assessed by routine blood gas analysis, hemodynamic effects, 30-day outcome and safety in comparison to Intermittent Positive Pressure Ventilation (IPPV) as data in humans is sparse especially in direct comparison to other ventilation modes.
Read full original descriptionShow less
Cardiac arrest patients in Vienna, Austria will be preclinically randomized (IPPV and CCSV) and ventilated accordingly during CPR. Differences in oxygenation, decarboxylation, systemic perfusion and cerebral oxygenation, the patient's 30-day outcome as well as ventilator-associated adverse events (e.g., pneumothorax) will be recorded and analyzed.
The 2 groups in the trial
- IPPV
Cardiac arrest patients ventilated with IPPV
- CCSV
Cardiac arrest patients ventilated with CCSV
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Chest Compression Synchronized Ventilation (CCSV) - An Exploratory Post Market Clinical Follow-up Study
- Record updated
- 20 July 2026